Clinical application of
Li Kaiquan UA and other study found that treatment of viral hepatitis in the preparation of drugs either alone or in conjunction with other medications, drugs or health as long as the drugs prepared were significant role in the treatment of viral hepatitis. They oleanolic acid as the control, treatment with UA A, 102 cases of acute hepatitis B, a dose of 102 and 60 mg · d ~, the average treatment time of 21 d, the cure rate was 89.3%, better than the same period 100 Example of oleanolic acid in the control group efficacy (68%, P <0.01); clinical trials, UA has a significant and rapid reduction of alanine aminotransferase, jaundice subsided and restore liver function. 3 weeks after medication, 21 patients with HBeAg-positive patients with negative rate was 61.9%, 21 cases of HBsAg-positive patients with negative rate of 42.8%, suggesting that the hepatitis B also have a therapeutic effect. In addition Tan Renxiang other studies have confirmed the UA not only has the role of treatment of viral hepatitis, it also has antidepressant effects, and the basil extract with UA as a treatment for depression drugs. UA almost no adverse reaction, compared to the narrow spectrum of anti-depressant medicine, toxic side effects, easy to relapse after treatment and induced suicidal tendencies, and there is a significant advantage. With UA as the main ingredient made of privet leaf extract capsules mainly used for liver and kidney, hyperactivity disorder due to primary hyperlipidemia, is China's second-class approved drugs.